Actionable news
All posts from Actionable news
Actionable news in SGMO: Sangamo BioSciences, Inc.,

Behring's long-acting hemophilia B treatment approved in Europe

The European Commission approves CSL Behring's Orphan Drug-tagged IDELVION [Coagulation Factor IX (Recombinant), Albumin Fusion Protein] for the treatment and prophylaxis of bleeding in patients of all ages with hemophilia B (factor IX deficiency). The labeling includes...